Wai Conrad's Form 4 filing
Clover Health Investments, Corp. (CLOV) · filed May 28, 2026
- Accession no.
- 0001971702-26-000010
- Filed
- May 28, 2026
- Trade date
- May 28, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction. Open-market sales total $879.5K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wai ConradCIK 0001971702 | Officer (CEO, Counterpart Health) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 28, 2026 | Class A Common Stock | SSaleDisposed | −220,426 | $3.99 | −$879,499.74 | 1,390,056 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.